INSP Form 4 reports disposition transactions

Buchholz Richard reported disposition transactions in a Form 4 filing for INSP.

Accepted by SEC EDGAR 02/11/2026 - 05:17 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Buchholz Richard reported disposition transactions in a Form 4 filing for INSP. The filing lists transactions totaling 327 shares at a weighted average price of $66.33 per share. Following the reported transactions, holdings were 44,567 shares.

Insider Trade Summary

Exercise Price or Tax Liability: 327 shares

Exercise Price or Tax Liability 1 txn

Insider Buchholz Richard

Role Interim CFO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	327	$66.33	$22K
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 44,567 shares (Direct); Common Stock — 2,950 shares (Indirect, By Son)

Footnotes (2)

1. F1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.
2. F2. Includes 27 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on December 31, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did INSP interim CFO Richard Buchholz report?

Richard Buchholz reported a tax-withholding disposition of 327 Inspire Medical Systems shares. These shares were withheld by the company on 02/09/2026 to satisfy taxes due upon vesting of a restricted stock unit award, rather than sold in the open market.

At what price were the 327 INSP shares withheld for taxes?

The 327 shares were withheld at a price of $66.33 per share. This price is used solely for reporting the value of the shares withheld to cover tax obligations related to the vesting restricted stock unit award on February 9, 2026.

How many INSP shares does Richard Buchholz own directly after this Form 4?

After the reported tax-withholding transaction, Richard Buchholz beneficially owns 44,567 shares of Inspire Medical Systems common stock directly. This amount includes 27 shares acquired through the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on December 31, 2025.

What indirect INSP share ownership is reported for Richard Buchholz?

The filing shows indirect beneficial ownership of 1,475 Inspire Medical Systems shares for Richard Buchholz. These shares are held “By Son,” indicating they are owned through his son while still being reportable as indirect beneficial ownership under SEC rules.

Was the INSP interim CFO’s Form 4 transaction a sale on the open market?

No, the transaction was classified under code F as a tax-withholding disposition. The company withheld 327 shares to satisfy tax obligations from vesting restricted stock units, meaning it was not a discretionary open-market purchase or sale by the interim CFO.

What does transaction code F mean in the INSP Form 4 filing?

Transaction code F indicates payment of a tax liability or exercise price by delivering or withholding securities. In this case, 327 Inspire Medical Systems shares were withheld to cover taxes triggered by the vesting of a restricted stock unit award for Richard Buchholz.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buchholz Richard

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		F		327(1)	D	$66.33	44,567(2)	D
Common Stock								1,475	I	By Son
Common Stock								1,475	I	By Son

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

2. Includes 27 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on December 31, 2025.

	/s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.